soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 found to lower risk of heart failure events in people with type 2 diabetes Heart disease is the #1

Raised intraocular pressure or glaucoma (rare, with prolonged corticosteroid use)

My latest for CNBC discusses how these new pills may not boost employer coverage.

Cataract surgery & procedure for cataracts from cataract surgeons at Baltimore.

We evaluated available evidence by searching PubMed and EMBASE databases, according to specific inclusion and exclusion eligibility criteria to evaluate gastrointestinal adverse events associated with GLP-1 RAs in non-diabetic individuals with overweight or obesity

New analyses show that drugs like Ozempic and Mounjaro aren't currently cost-effective, even if they deliver the most optimistic long-term health benefits.

Bevat gepatenteerde botanische extracten Metabolaid (citroenverbena & hibiscus) en Eriomin (citrusbioflavonoden)